Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02727023 · ClinicalTrials.gov registry record · NA
Effect of OMM on Anandamide Levels in Saliva
A NA study, sponsored by New York Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02727023: Completed NA study, sponsored by New York Institute of Technology.
NCT02727023 is a NA study that has completed, run by New York Institute of Technology. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02727023, a NA study, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The Investigators will be studying the effects of Osteopathic Manipulative Lymphatic Pump Treatment on levels of anandamide in Saliva. A qualitative scale will also be used to measure the canabinomimetic effects of osteopathic treatment.
Primary Outcome
The Investigators will be studying the effects of Osteopathic Manipulative Lymphatic Pump Treatment on levels of anandamide in Saliva. A qualitative scale will also be used to measure the canabinomimetic effects of osteopathic treatment.
Interventions
- OTHER Osteopathic Manipulative Medicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT02727023 record still lists
NCT02727023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Osteopathic Manipulative Medicine is the first listed.
NCT02727023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02727023 about?
NCT02727023 is a clinical study titled "Effect of OMM on Anandamide Levels in Saliva". The Investigators will be studying the effects of Osteopathic Manipulative Lymphatic Pump Treatment on levels of anandamide in Saliva. A qualitative scale will also be used to measure the canabinomimetic effects of osteopathic treatment.
What is the current status of trial NCT02727023?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2015-12. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02727023?
The interventions under investigation include: Osteopathic Manipulative Medicine (OTHER).
Who is sponsoring clinical trial NCT02727023?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02727023's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia